Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study.

Lo Re V 3rd, Teal V, Localio AR, Amorosa VK, Kaplan DE, Gross R.

Ann Intern Med. 2011 Sep 20;155(6):353-60. doi: 10.7326/0003-4819-155-6-201109200-00003.

2.

Current therapy for hepatitis C.

Friedrich-Rust M, Zeuzem S, Sarrazin C.

Int J Colorectal Dis. 2007 Apr;22(4):341-9. Epub 2005 Sep 21. Review.

PMID:
16175369
3.

From non-A, non-B hepatitis to hepatitis C virus cure.

Pawlotsky JM, Feld JJ, Zeuzem S, Hoofnagle JH.

J Hepatol. 2015 Apr;62(1 Suppl):S87-99. doi: 10.1016/j.jhep.2015.02.006. Review.

4.

Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection.

Feld JJ, Jacobson IM, Sulkowski MS, Poordad F, Tatsch F, Pawlotsky JM.

Liver Int. 2017 Jan;37(1):5-18. doi: 10.1111/liv.13212. Epub 2016 Sep 29. Review.

5.

Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis.

Dimova RB, Zeremski M, Jacobson IM, Hagan H, Des Jarlais DC, Talal AH.

Clin Infect Dis. 2013 Mar;56(6):806-16. doi: 10.1093/cid/cis1007. Epub 2012 Dec 7. Review.

6.

Liver transplantation from HCV RNA-positive donors in the era of interferon-free HCV therapeutics: a re-examination of the situation.

Willuweit K, Canbay A, Gerken G, Timm J, Paul A, Treckmann J, Herzer K.

Minerva Gastroenterol Dietol. 2017 Mar;63(1):55-61. doi: 10.23736/S1121-421X.16.02347-3. Epub 2016 Nov 8. Review.

PMID:
27824245
7.

Hepatitis C treatment update.

Pearlman BL.

Am J Med. 2004 Sep 1;117(5):344-52. Review.

PMID:
15336584
8.

Factors influencing adherence in Hepatitis-C infected patients: a systematic review.

Mathes T, Antoine SL, Pieper D.

BMC Infect Dis. 2014 Apr 15;14:203. doi: 10.1186/1471-2334-14-203. Review.

9.

Burden of pediatric hepatitis C.

El-Shabrawi MH, Kamal NM.

World J Gastroenterol. 2013 Nov 28;19(44):7880-8. doi: 10.3748/wjg.v19.i44.7880. Review.

10.

Review article: adherence to medication for chronic hepatitis C - building on the model of human immunodeficiency virus antiretroviral adherence research.

Weiss JJ, Bräu N, Stivala A, Swan T, Fishbein D.

Aliment Pharmacol Ther. 2009 Jul;30(1):14-27. doi: 10.1111/j.1365-2036.2009.04004.x. Epub 2009 Mar 26. Review.

11.

Antiviral therapy for chronic hepatitis C: past, present, and future.

Hayashi N, Takehara T.

J Gastroenterol. 2006 Jan;41(1):17-27. Review.

PMID:
16501853
13.

Relapsing polychondritis associated with hepatitis C virus infection.

Hemmati I, Yoshida E, Shojania K.

Clin Rheumatol. 2012 Feb;31(2):391-4. doi: 10.1007/s10067-011-1881-4. Epub 2011 Nov 4. Review.

PMID:
22052586
14.

Advances in therapy for hepatitis C infection.

Zein CO, Zein NN.

Microbes Infect. 2002 Oct;4(12):1237-46. Review.

PMID:
12467765
16.

Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection.

Cloherty G, Talal A, Coller K, Steinhart C, Hackett J Jr, Dawson G, Rockstroh J, Feld J.

J Clin Microbiol. 2016 Feb;54(2):265-73. doi: 10.1128/JCM.02407-15. Epub 2015 Dec 9. Review.

17.

Modulation of host lipid metabolism by hepatitis C virus: Role of new therapies.

Del Campo JA, Romero-Gómez M.

World J Gastroenterol. 2015 Oct 14;21(38):10776-82. doi: 10.3748/wjg.v21.i38.10776. Review.

18.

Hepatitis C Treatment: Clinical Issues for Psychiatrists in the Post-Interferon Era.

Chasser Y, Kim AY, Freudenreich O.

Psychosomatics. 2017 Jan - Feb;58(1):1-10. doi: 10.1016/j.psym.2016.09.004. Epub 2016 Sep 14. Review.

PMID:
27871760

Supplemental Content

Support Center